These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7830962)

  • 1. Effects of aporphine isomers on rat prolactin.
    Baldessarini RJ; Campbell A; Ben-Jonathan N; Ellingboe J; Zong R; Neumeyer JL
    Neurosci Lett; 1994 Aug; 176(2):269-71. PubMed ID: 7830962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines.
    Booth RG; Baldessarini RJ; Kula NS; Gao Y; Zong R; Neumeyer JL
    Mol Pharmacol; 1990 Jul; 38(1):92-101. PubMed ID: 1973525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
    Cosi C; Carilla-Durand E; Assié MB; Ormiere AM; Maraval M; Leduc N; Newman-Tancredi A
    Eur J Pharmacol; 2006 Mar; 535(1-3):135-44. PubMed ID: 16554049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of isomers of hydroxyaporphines on dopamine metabolism in rat brain regions.
    Baldessarini RJ; Marsh ER; Kula NS; Zong RS; Gao YG; Neumeyer JL
    Biochem Pharmacol; 1990 Aug; 40(3):417-23. PubMed ID: 2383279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and dopamine receptor affinities of N-alkyl-11-hydroxy-2-methoxynoraporphines: N-alkyl substituents determine D1 versus D2 receptor selectivity.
    Si YG; Gardner MP; Tarazi FI; Baldessarini RJ; Neumeyer JL
    J Med Chem; 2008 Feb; 51(4):983-7. PubMed ID: 18251489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of S(+)N-n-propylnorapomorphine compared with typical and atypical antipsychotics: differential increases of cerebrocortical D2-like and striatolimbic D4-like dopamine receptors.
    Tarazi FI; Yeghiayan SK; Baldessarini RJ; Kula NS; Neumeyer JL
    Neuropsychopharmacology; 1997 Sep; 17(3):186-96. PubMed ID: 9272485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor affinities of aporphine enantiomers in rat brain tissue.
    Baldessarini RJ; Kula NS; Zong R; Neumeyer JL
    Eur J Pharmacol; 1994 Mar; 254(1-2):199-203. PubMed ID: 7911429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. R(-) and S(+) stereoisomers of 11-hydroxy- and 11-methoxy-N-n-propylnoraporphine: central dopaminergic behavioral activity in the rat.
    Campbell A; Baldessarini RJ; Gao Y; Zong R; Neumeyer JL
    Neuropharmacology; 1990 Jun; 29(6):527-36. PubMed ID: 1974710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimal effects of JL 13, a pyridobenzoxazepine derivative with an antipsychotic potential, on circulating prolactin levels in male rats.
    Liégeois JF; Bruhwyler J; Hendrick JC; Delarge J; Legros JJ; Damas J
    Neurosci Lett; 2002 Feb; 319(1):49-52. PubMed ID: 11814651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and dopamine agonist and antagonist effects of (R)-(-)- and (S)-(+)-11-hydroxy-N-n-propylnoraporphine.
    Gao Y; Zong R; Campbell A; Kula NS; Baldessarini RJ; Neumeyer JL
    J Med Chem; 1988 Jul; 31(7):1392-6. PubMed ID: 3385732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Slow dissociation of partial agonists from the D₂ receptor is linked to reduced prolactin release.
    Carboni L; Negri M; Michielin F; Bertani S; Fratte SD; Oliosi B; Cavanni P
    Int J Neuropsychopharmacol; 2012 Jun; 15(5):645-56. PubMed ID: 21733233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the dopamine stabilizers (S)-(-)-OSU6162 and ACR16 on prolactin secretion in drug-naive and monoamine-depleted rats.
    Rung JP; Rung E; Johansson AM; Svensson K; Carlsson A; Carlsson ML
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Jul; 384(1):39-45. PubMed ID: 21533991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective antidopaminergic effects of S(+)N-n-propylnoraporphines in limbic versus extrapyramidal sites in rat brain: comparisons with typical and atypical antipsychotic agents.
    Campbell A; Yeghiayan S; Baldessarini RJ; Neumeyer JL
    Psychopharmacology (Berl); 1991; 103(3):323-9. PubMed ID: 1676180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine D(2) activity of R-(-)-apomorphine and selected analogs: a microdialysis study.
    Rodenhuis N; Dijkstra D; de Boer P; Vermeulen ES; Timmerman W; Wikström HV
    Eur J Pharmacol; 2000 Jan; 387(1):39-45. PubMed ID: 10633158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered spontaneous behavior and sensitivity to apomorphine in rats following pretreatment with S(+)-aporphines or fluphenazine.
    Campbell A; Baldessarini RJ; Neumeyer JL
    Psychopharmacology (Berl); 1993; 111(3):351-8. PubMed ID: 7870974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aporphines. 15. Action of aporphine alkaloids on dopaminergic mechanisms in rat brain.
    Miller RJ; Kelly PH; Neumeyer JL
    Eur J Pharmacol; 1976 Jan; 35(1):77-83. PubMed ID: 943290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Actions of novel antipsychotic agents on apomorphine-induced PPI disruption: influence of combined serotonin 5-HT1A receptor activation and dopamine D2 receptor blockade.
    Auclair AL; Kleven MS; Besnard J; Depoortère R; Newman-Tancredi A
    Neuropsychopharmacology; 2006 Sep; 31(9):1900-9. PubMed ID: 16421514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 2-bromoterguride, a dopamine D
    Tarland E; Franke RT; Fink H; Pertz HH; Brosda J
    Psychopharmacology (Berl); 2018 Jan; 235(1):99-108. PubMed ID: 28971230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aporphines. 14 Dopaminergic and antinociceptive activity of aporphine derivatives. Synthesis of 10-hydroxyaporphines and 10-hydroxy-N-n-propylnoraporphine.
    Neumeyer JL; Reinhard JF; Dafeldecker WP; Guarino J; Kosersky DS; Fuxe K; Agnati L
    J Med Chem; 1976 Jan; 19(1):25-9. PubMed ID: 942751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of dopamine supersensitivity in rats after chronic administration of blonanserin: Comparison with haloperidol.
    Hashimoto T; Baba S; Ikeda H; Oda Y; Hashimoto K; Shimizu I
    Eur J Pharmacol; 2018 Jul; 830():26-32. PubMed ID: 29684390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.